Atlas Trials

Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

Clinical trial NCT02771574 · COMPLETED

Trial details

NCT number
NCT02771574
Sponsor
Tracey McLaughlin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Post Bariatric Hypoglycemia
Start date
2016-05-01
Primary completion
2017-06-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.